Magnetic Resonance Imaging Market to Witness Growth Due to The Increasing Demand for Scans


The traditional magnetic resonance imaging (MRI) approach is being disrupted by portable MRI systems, open design MRI systems, advanced metamaterials, and integration of artificial intelligence (AI) and advanced software technologies. The rising demand for scans, combined with a shortage of radiologists, has compelled the development of novel MRI technologies that shorten scan times and aid radiologists’ decision-making. The increasing prevalence of cardiovascular diseases and cancer, combined with government initiatives to provide free or low-cost diagnostic facilities and infrastructure to citizens, is driving the overall growth of MRI technology.

For further information on this analysis, please click here.

“Innovations in MRI imaging device’s design, AI integration, and audiovisual systems have improved the image quality, patient experience, and reduced scan time,” said Ashish Kaul, Healthcare Industry Analyst at Frost & Sullivan. “Additionally, MRI innovation, such as material-based products to enhance image quality, coil design for portable systems, and AI for image analysis, will increase care delivery for patients and take center stage during the next 3 years.”

Kaul added: “Companies that offer portable imaging systems is addressing the market need for a de-centralized care delivery and is challenging the established market participants that offer stationary MRI systems and compelling them to rethink their competitive strategy. Further, new AI-based image analysis software that enhances magnetic resonance (MR) image quality and supports clinical decision-making is making the market even more competitive for technology developers.”

To reap the benefits of the expanding MRI technology innovation industry, market participants should:

  • Explore materials that can enhance MR image quality, such as magnetic metamaterials, in multiple applications.
  • Collaborate with local vendors to utilize cloud platforms for data storage and processing as it ensures that healthcare facilities comply with regional data regulations on patients’ health data.
  • Either invest in research and development (R&D) activities internally or fund university-level research projects to explore the potential applications of portable MRI systems beyond neurology.

Magnetic Resonance Imaging (MRI): Technology Innovation and Growth Opportunities is the latest addition to Frost & Sullivan’s Healthcare research and analysis available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.


Respiratory Health Management Market to Expedite Digital, Smart, and Portable Solutions


The COVID-19 outbreak has inflated the demand for smart and digitally connected medical devices such as artificial intelligence (AI)-based mobile medical applications and medical imaging software, ensuring better management of severe respiratory diseases. Innovative medical devices such as mobile medical applications and inhalers are the mainstay of the respiratory disease management industry. However, the high costs of devices, heavy competition, absence of real-time feedback, and lack of awareness among patients have restricted the adoption of such technologies.

For further information on this analysis, Respiratory Health Management Technology Growth Opportunities, please visit:

“The respiratory health market is focusing on technology convergence; integrating digital and sensor technologies to create smart, portable, and connected medical devices; and improving clinical outcomes and patient engagement during the disease management process,” said Ashish Kaul, Senior Research Analyst, TechVision, at Frost & Sullivan.

Kaul added: “Mobile medical applications for the diagnosis and management of respiratory diseases can reduce the cost of medical care by eliminating the need for regular medical tests. Further, smart medical devices such as inhalers that offer personalized insights and care anywhere are expected to increase the adoption of a home-based disease management regime in the next one to two years, as it follows the current trend of remote care.”

As mobile medical applications, oxygen concentrators, and smart inhalers are experiencing significant innovations fueled by the COVID-19 pandemic, market participants can focus on the following to tap into these growth opportunities:

  • Smart inhaler capable of providing feedback and support: Pharmaceutical companies can collaborate or partner with innovative start-ups that offer real-time feedback on the inhaler technique and use acoustic technology for drug delivery to the patients.
  • Innovative and durable oxygen concentrators: Health technology companies and innovators can partner to explore opportunities to produce improved, durable, and easy-to-operate oxygen concentrators for hospital and home purposes.
  • Innovative mobile medical applications: Innovators should invest in research-based evidence to showcase the effectiveness of mobile medical applications in the improved management of respiratory diseases.

Respiratory Health Management Technology Growth Opportunities is the latest addition to Frost & Sullivan’s Healthcare research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.